GenMark Diagnostics Reports Third Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GenMark Diagnostics (GNMK) Halted on LUDP
November 3, 2017 9:54 AM EDTGenMark Diagnostics (NASDAQ: GNMK) Halted on LUDP
... MoreGenMark Diagnostics (GNMK) PT Lowered to $10 at Cowen Following 3Q Miss
November 3, 2017 8:15 AM EDTCowen lowered its price target on GenMark Diagnostics (NASDAQ: GNMK) to $10.00 (from $17.00) while maintaining a Outperform rating following the company's 3Q. Revenue of $11.6MM was $3MM below consensus.
Management reduced full year revenue guidance to $51-53MM from $65-70MM. Management attributed the... More
GenMark Diagnostics (GNMK) Misses Q3 EPS by 2c
November 2, 2017 4:57 PM EDTGenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $14.56 million.
For full year 2017, GenMark expects revenue to range from $51 - $53 million and gross margin... More
